8-K: Aditxt Faces Nasdaq Delisting, Implements 1-for-250 Reverse Stock Split

Aditxt, Inc. announces a 1-for-250 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement after receiving a delisting notification.

Summary

• Aditxt, Inc. received a notification from Nasdaq on March 7, 2025, stating that it is subject to delisting due to its stock price closing at $0.10 or less for ten consecutive trading days.
• The company intends to appeal the delisting decision to the Nasdaq Hearings Panel on March 14, 2025.
• Aditxt's stockholders previously approved a reverse stock split at a special meeting.
• The board of directors approved a 1-for-250 reverse stock split, which will be effective on March 14, 2025, at 4:01 p.m. Eastern Time.
• Trading on a split-adjusted basis will begin on March 17, 2025.
• The reverse stock split is primarily intended to bring the company into compliance with Nasdaq's minimum bid price requirement.
• Immediately after the reverse stock split becomes effective, the Company will have approximately 1,031,102 shares of common stock issued and outstanding.
• The company's common stock will continue to trade on the Nasdaq Stock Market LLC under the existing symbol ADTX, but the security has been assigned a new CUSIP number (007025802).

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notification and the need for a reverse stock split, indicating financial distress and uncertainty about the company's future.

Positives

• The company is taking action to regain compliance with Nasdaq's minimum bid price requirement through a reverse stock split.
• Aditxt is appealing the delisting decision, which will stay the delisting and suspension of the company's securities pending the decision of the Nasdaq Hearings Panel.

Negatives

• Aditxt received a delisting notification from Nasdaq, indicating a failure to maintain the minimum bid price requirement.
• The company's stock price has fallen below $0.10 for ten consecutive trading days.

Risks

• There is no assurance that the company will be able to evidence compliance with the minimum bid price rules or any other applicable requirements for continued listing on The Nasdaq Capital Market prior to the hearing.
• The Nasdaq Hearings Panel may not rule in the company's favor, potentially leading to delisting.
• The company's ability to close the transactions with Appili and Evofem is subject to several conditions, including raising sufficient capital.

Future Outlook

The company intends to present its views and plans to regain compliance with Nasdaq's minimum bid price rules to the Nasdaq Hearings Panel.

Management Comments

• Aditxt is an innovation platform dedicated to discovering, developing, and deploying promising health innovations.
• Aditxt operates a unique model that democratizes innovation, ensures every stakeholders voice is heard and valued, and empowers collective progress.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting due to low stock prices, particularly in the biotechnology and pharmaceutical industries where stock prices can be volatile.

Comparison to Industry Standards

• Many companies facing similar delisting notices implement reverse stock splits to regain compliance, but their success varies depending on the underlying business fundamentals and market conditions.
• Comparable companies that have recently undertaken reverse stock splits include those in the biotech and small-cap sectors facing similar compliance issues with Nasdaq or NYSE listing requirements.

Stakeholder Impact

• Shareholders will experience a significant reduction in the number of shares they own due to the reverse stock split.
• The reverse stock split could impact the market perception of the company and its stock price.
• Employees may be concerned about the company's financial stability and future prospects.

Next Steps

• Aditxt intends to submit an appeal to Nasdaq on March 14, 2025.
• The company will present its views and plans to regain compliance with Nasdaq's minimum bid price rules to the Nasdaq Hearings Panel.
• The company will monitor the trading price of its common stock post-reverse split to ensure compliance with Nasdaq's minimum bid price requirement.

Key Dates